Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

An analysis of anticoagulant adverse drug events in a large community teaching hospital

Authors: Z. Khudeira, Satish Jain

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Excerpt

Annually, over 770,000 people are injured or die in hospitals from adverse drug events (ADEs). Patients who experience an ADE are hospitalized an average of 8–12 days longer than patients who do not suffer an ADE. Treatment with anticoagulants can lead to ADEs. Advocate Christ Medical Center’s (ACMC) Pharmacy Department reviewed its anticoagulant ADEs. A retrospective analysis was conducted to identify all ADEs associated with anticoagulants for a twelve month period. All hospitalized patients were identified using the ADE code from the patient’s chart. Each chart was analyzed for the following: type of anticoagulant, severity of ADE, INR value, treatment offered, adherence to American College of Chest Physicians (ACCP) Guidelines for Vitamin K1 administration, and was anticoagulant the reason for hospital admission. There were 1,765 ADEs reported for the year of 2005. Anticoagulants accounted for 227 (13.2%) of all ADEs. Patients receiving warfarin with a supratherapeutic INR were further analyzed to determine adherence to ACCP’s guidelines for the use of Vitamin K1. There were 109 patients who received Vitamin K1, of which 102 (94%) received it appropriately. Forty-eight percent of anticoagulant ADEs were identified as the reason for hospital admission. Thirty-seven percent of the admitted patients required a prolonged stay due to the severity of the ADE. Seventy-six percent of the anticoagulant ADEs were due to warfarin and only 10.6% was due to heparin. Anticoagulants are high-alert medications that are indicated for many disease states. Hospitals need to annually analyze and identify areas for improvement. Interventions to reduce anticoagulant ADEs need to be implemented. The data reveals that there is a high volume of patients that present to the hospital or have a prolonged length of stay secondary to an anticoagulant ADE. Pharmacist intervention in the Anticoagulation Clinic should decrease the number of ADEs therefore decreasing length of stay as well as overall health costs. …
Metadata
Title
An analysis of anticoagulant adverse drug events in a large community teaching hospital
Authors
Z. Khudeira
Satish Jain
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0129-2

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.